← Open Payments lookup

KAYLA DAVISON: Open Payments

NPI 1447638895 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$387 in 18 payments from 13 companies in 2025. Trend: 2023 $234 · 2024 $328 · 2025 $387

Food & beverage: $387
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$136
Astellas Pharma US Inc1$40
Actelion Pharmaceuticals US, Inc.2$35
Ascensia Diabetes Care Us Inc.1$21
Medtronic, Inc.1$21
Otsuka America Pharmaceutical, Inc.1$21
Novo Nordisk Inc1$18
SANOFI-AVENTIS U.S. LLC1$18
Gilead Sciences, Inc.1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$16

Products named: BREZTRI, AIRSUPRA, Veozah, OPSUMIT, SYMPLICITY G3, REXULTI, Ozempic, TZIELD.

Industry payments across NE — which companies pay providers there.